Deborah DuFresne has joined InnoPharma as VP, strategic portfolio selection and management.
She joins the US-based company from Impax Laboratories where she was senior director, project management, product identification and development.
DuFresne has also held senior roles at Fera Pharmaceuticals, Sandoz and Apotex.
“Deborah’s broad generic and specialty pharmaceutical experience and extensive product knowledge will be vital to InnoPharma as we seek to enhanc our portfolio in a strategic manner,” said InnoPharma’s president and CEO Dr Navneet Puri.
“We look forward to working with Deborah as we continue to build our business and execute on our goals.”